NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/13/2022
Back to search
Official data from USPTO
SEBELA PHARMACEUTICALS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
SEBELA PHARMACEUTICALS
ST13
US500000088371925Class
5
Filing
88371925
Registration
6925202
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
45
Latest update
12/13/2022
Trademark type
Word
Nice classes
5
Filing date
04/04/2019
Registration date
12/13/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/13/2022
Last transaction
12/13/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
11/06/2017
First use in commerce
11/06/2017
Drawing code
4
Owner type
11
Owner location
DUBLIN, IE
Examiner
DAWE III, WILLIAM H
Law office
L80
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
SEBELA IRELAND LIMITED
SEBELA INTERNATIONAL BERMUDA LIMITED
Representatives
Jeffrey H. Handelsman GREENBLUM & BERNSTEIN, P.L.C.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical and medicated preparations for use in neurology; preparations for the suppression of hormones; pharmaceutical preparations and substances directed to women's health for use in the treatmentalleviation and prevention of female sexual dysfunction; all of the aforesaid goods not for use as a product name of a pharmaceutical product
Publications
History of USPTO decisions and trademark events.
45 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
12/13/2022
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
11/08/2022
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
11/07/2022
SUPC
STATEMENT OF USE PROCESSING COMPLETE
10/25/2022
IUAF
USE AMENDMENT FILED
10/17/2022
EISU
TEAS STATEMENT OF USE RECEIVED
10/17/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
04/20/2022
EX5G
SOU EXTENSION 5 GRANTED
04/19/2022
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
04/19/2022
EXT5
SOU EXTENSION 5 FILED
04/13/2022
EEXT
SOU TEAS EXTENSION RECEIVED
04/13/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
10/16/2021
EX4G
SOU EXTENSION 4 GRANTED
10/14/2021
EXT4
SOU EXTENSION 4 FILED
10/14/2021
EEXT
SOU TEAS EXTENSION RECEIVED
10/14/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
04/15/2021
EX3G
SOU EXTENSION 3 GRANTED
04/13/2021
EXT3
SOU EXTENSION 3 FILED
04/13/2021
EEXT
SOU TEAS EXTENSION RECEIVED
04/13/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
10/16/2020
EX2G
SOU EXTENSION 2 GRANTED
10/14/2020
EXT2
SOU EXTENSION 2 FILED
10/14/2020
EEXT
SOU TEAS EXTENSION RECEIVED
10/14/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
04/17/2020
EX1G
SOU EXTENSION 1 GRANTED
04/15/2020
EXT1
SOU EXTENSION 1 FILED
04/15/2020
EEXT
SOU TEAS EXTENSION RECEIVED
04/15/2020
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
10/15/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/20/2019
PUBO
PUBLISHED FOR OPPOSITION
08/20/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/31/2019
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
07/24/2019
ALIE
ASSIGNED TO LIE
07/15/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/08/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
07/08/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
07/08/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
07/08/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
07/08/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/14/2019
GNRT
NON-FINAL ACTION E-MAILED
06/14/2019
CNRT
NON-FINAL ACTION WRITTEN
06/14/2019
DOCK
ASSIGNED TO EXAMINER
06/14/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/22/2019
NWAP
NEW APPLICATION ENTERED
04/08/2019
Continuous trademark protection
Get notified about every new filing that threatens SEBELA PHARMACEUTICALS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.